LEADER 00948nam0-2200301---450- 001 990008311850403321 005 20100427133056.0 035 $a000831185 035 $aFED01000831185 035 $a(Aleph)000831185FED01 035 $a000831185 100 $a20060412d1967----km-y0itay50------ba 101 0 $aeng 102 $aUS 105 $aa-------001yy 200 1 $aDesign of active-site-directed irreversible enzyme inhibitors$ethe organic chemistry of the enzymic active-site$fB. R. Baker 210 $aNew York$cJohn Wiley and Sons$d1967 215 $aXIII, 325 p.$cill.$d23 cm 610 0 $aEnzimi 676 $a574.1925 700 1$aBaker,$bBernard Randall$f<1915- >$0320567 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008311850403321 952 $a80 VII B 83 CFT (4)$bCFT 5291$fFFABC 959 $aFFABC 996 $aDesign of active-site-directed irreversible enzyme inhibitors$9745515 997 $aUNINA LEADER 01383nam0 22003133i 450 001 VAN0249211 005 20220823091651.34 017 70$2N$a978-981-15-8640-8 100 $a20220823d2021 |0itac50 ba 101 $aeng 102 $aSG 105 $a|||| ||||| 200 1 $aMathematical Models of Cancer and Different Therapies$eUnified Framework$fRegina Padmanabhan, Nader Meskin, Ala-Eddin Al Moustafa 210 $aSingapore$cSpringer$d2021 215 $aXVI, 256 p.$cill.$d24 cm 410 1$1001VAN0109541$12001 $aSeries in BioEngineering$1210 $aCham$cSpringer$d2013- 620 $aSG$dSingapore$3VANL000061 700 1$aPadmanabhan$bRegina$3VANV203873$01225157 701 1$aAl Moustafa$bAla-Eddin$3VANV093833$01252768 701 1$aMeskin$bNader$3VANV203874$01252769 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240614$gRICA 856 4 $uhttps://link.springer.com/book/10.1007/978-981-15-8640-8$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN0249211 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 9643 $e15EB 9643 20220823 996 $aMathematical Models of Cancer and Different Therapies$92904447 997 $aUNICAMPANIA